SCHEMBL1119552

SCHEMBL1119552

[CH2]c1ccc(OC(F)(F)C(F)(F)C(F)(F)F)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1119536 0.94
SCHEMBL1119538 0.92 LMNA (0.31)
SCHEMBL1119532 0.92 LMNA (0.31)
SCHEMBL1119553 0.86 MAPT (0.31)
SCHEMBL9578601 0.78 ESR2 (0.42)
SCHEMBL10524397 0.78 ACHE (0.41)
SCHEMBL1258083 0.78 TRPV1 (0.40)
SCHEMBL9222256 0.77
SCHEMBL97453 0.77 MAPT (0.47)
SCHEMBL9225751 0.75 KCNH2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895599-B2 Lipoprotein lipase-activating compositions comprising benzene derivates OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2014-11-25 US disclosed
US-20130296342-A1 LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATES OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2013-11-07 US disclosed
EP-2280706-B1 LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATIVES OTSUKA PHARMA CO LTD (JP) 2013-01-02 EP disclosed
US-20110065728-A1 LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATIVES OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2011-03-17 US disclosed
EP-2280706-A1 LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATES Otsuka Pharmaceutical Factory, Inc. (JP) 2011-02-09 EP disclosed
WO-2009139076-A1 LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATES OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2009-11-19 WO disclosed